Abstract

Relevance: Meningioma has many forms, each with a specific histological structure and treatment tactics. Meningiomas are the most
 common intracranial neoplasms, most of which have an extracerebral location, and their intraparenchymal location is rare.
 The purpose was to describe a case of treatment of intraparenchymal chordoid meningioma.
 Methods: The article describes a case of treatment of intraparenchymal chordoid meningioma, which is rare in localization, structure, and
 possible combination with other systemic diseases.
 Results: Patient B. was admitted to the clinic for surgical treatment for an intracranial neoplasm; the main complaints were the presence
 of seizures and their transition to epileptic status. The tumor was removed completely, after which it was sent for further histological and
 immunohistochemical examination. The examination of micro slides revealed the presence of chordoid meningioma in the patient. In the
 postoperative period, as well as at control examination after 3 months, the patient showed a decrease in the number of seizures and no transition
 to epileptic status. MRI control showed no relapse of tumor growth.
 Conclusion: WHO classifies chordoid meningioma as a rare grade II meningioma. Chordoid meningioma often requires further radiation
 therapy, especially with partial or subtotal removal, due to a slightly higher risk of relapse compared to grade I meningiomas. This disease can
 occur independently or in association with Castleman syndrome and can be asymptomatic for a long time; this requires further follow-up of
 the patient.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.